Latest & greatest articles for cannabis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on cannabis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on cannabis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for cannabis

121. Systematic review and meta-analysis of cannabis treatment for chronic pain

Systematic review and meta-analysis of cannabis treatment for chronic pain Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

122. Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review

Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

123. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia (PubMed)

Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia Cannabis-induced psychosis is considered a distinct clinical entity in the existing psychiatric diagnostic systems. However, the validity of the diagnosis is uncertain.To establish rate ratios of developing cannabis-induced psychosis associated with predisposition to psychosis and other psychiatric disorders in a first-degree relative and to compare them (...) with the corresponding rate ratios for developing schizophrenia spectrum disorders.A population-based cohort was retrieved from the Danish Psychiatric Central Register and linked with the Danish Civil Registration System. History of treatment of psychiatric disorder in family members was used as an indicator of predisposition to psychiatric disorder. Rate ratios of cannabis-induced psychosis and schizophrenia associated with predisposition to psychiatric disorders were compared using competing risk

Full Text available with Trip Pro

2008 EvidenceUpdates

124. Cannabis and schizophrenia. (PubMed)

Cannabis and schizophrenia. Many people with schizophrenia use cannabis and its effects on the illness are unclear.To evaluate the effects of cannabis use on people with schizophrenia and schizophrenia-like illnesses.We searched the Cochrane Schizophrenia Group Trials Register (April 2007) which is based on regular searches of BIOSIS, CENTRAL, CINAHL, EMBASE, MEDLINE and PsycINFO.We included all randomised trials involving cannabinoids and people with schizophrenia or schizophrenia-like (...) illnesses.We extracted data independently. For dichotomous data we calculated relative risks (RR) and their 95% confidence intervals (CI) on an intention-to-treat basis, based on a fixed effects model. We calculated the numbers needed to treat/harm (NNT/NNH). For continuous data, we calculated weighted mean differences (WMD) again based on a fixed effects model.We identified one randomised trial. No significant differences were found between the Cannabis and Psychosis Therapy (CAP) intervention group

Full Text available with Trip Pro

2008 Cochrane

125. Cannabis use increases risk of developing symptoms of mania

Cannabis use increases risk of developing symptoms of mania Cannabis use increases risk of developing symptoms of mania | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name (...) or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Cannabis use increases risk of developing symptoms of mania Article Text Aetiology Cannabis use increases risk of developing symptoms of mania Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which

2008 Evidence-Based Mental Health

126. Cannabis smoking and periodontal disease among young adults. (PubMed)

Cannabis smoking and periodontal disease among young adults. Tobacco smoking is a recognized behavioral risk factor for periodontal disease (through its systemic effects), and cannabis smoking may contribute in a similar way.To determine whether cannabis smoking is a risk factor for periodontal disease.Prospective cohort study of the general population, with cannabis use determined at ages 18, 21, 26, and 32 years and dental examinations conducted at ages 26 and 32 years. The most recent data (...) sites per tooth.Three cannabis exposure groups were determined: no exposure (293 individuals, or 32.3%), some exposure (428; 47.4%), and high exposure (182; 20.2%). At age 32 years, 265 participants (29.3%) had 1 or more sites with 4 mm or greater CAL, and 111 participants (12.3%) had 1 or more sites with 5 mm or greater CAL. Incident attachment loss between the ages of 26 and 32 years in the none, some, and high cannabis exposure groups was 6.5%, 11.2%, and 23.6%, respectively. After controlling

Full Text available with Trip Pro

2008 JAMA

127. Short scales to assess cannabis-related problems: a review of psychometric properties

Short scales to assess cannabis-related problems: a review of psychometric properties Short scales to assess cannabis-related problems: a review of psychometric properties Short scales to assess cannabis-related problems: a review of psychometric properties Piontek D, Kraus L, Klempova D CRD summary This review concluded that all four screening tools to assess cannabis-related problems showed satisfactory measures of reliability and validity. Limitations in the review, in particular (...) the possibility of publication bias and unclear validity of the included studies, means that these conclusions should be interpreted with caution. Authors' objectives To summarise the psychometric properties of four short screening scales to assess problematic forms of cannabis use. Searching PubMed, PsycINFO and Addiction Abstracts were searched (dates not reported) for peer reviewed published studies. Search terms were reported. The Internet was searched and reference lists of retrieved studies were

Full Text available with Trip Pro

2008 DARE.

128. Review: use of cannabis is associated with increased risk of psychotic outcomes later in life

Review: use of cannabis is associated with increased risk of psychotic outcomes later in life Review: use of cannabis is associated with increased risk of psychotic outcomes later in lifeCommentary | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: use of cannabis is associated with increased risk of psychotic outcomes later in lifeCommentary Article Text Causation Review: use of cannabis is associated with increased risk of psychotic

2008 Evidence-Based Nursing

129. Review: Cannabis use increases the risk of psychotic outcomes

Review: Cannabis use increases the risk of psychotic outcomes Review: Cannabis use increases the risk of psychotic outcomes | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user (...) name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: Cannabis use increases the risk of psychotic outcomes Article Text Aetiology Review: Cannabis use increases the risk of psychotic outcomes Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link

2008 Evidence-Based Mental Health

130. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis

Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2008 DARE.

131. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. (PubMed)

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Whether cannabis can cause psychotic or affective symptoms that persist beyond transient intoxication is unclear. We systematically reviewed the evidence pertaining to cannabis use and occurrence of psychotic or affective mental health outcomes.We searched Medline, Embase, CINAHL, PsycINFO, ISI Web of Knowledge, ISI Proceedings, ZETOC, BIOSIS, LILACS, and MEDCARIB from their inception to September, 2006 (...) , searched reference lists of studies selected for inclusion, and contacted experts. Studies were included if longitudinal and population based. 35 studies from 4804 references were included. Data extraction and quality assessment were done independently and in duplicate.There was an increased risk of any psychotic outcome in individuals who had ever used cannabis (pooled adjusted odds ratio=1.41, 95% CI 1.20-1.65). Findings were consistent with a dose-response effect, with greater risk in people who

Full Text available with Trip Pro

2007 Lancet

132. Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain

Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2007 DARE.

133. Cannabis use increases the risk of young people developing psychotic symptoms, particularly if already predisposed

Cannabis use increases the risk of young people developing psychotic symptoms, particularly if already predisposed Cannabis use increases the risk of young people developing psychotic symptoms, particularly if already predisposed | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Cannabis use increases the risk of young people developing psychotic symptoms, particularly if already predisposed Article Text Aetiology Cannabis use increases

Full Text available with Trip Pro

2006 Evidence-Based Mental Health

134. Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings. (PubMed)

Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings. Cannabis use disorder is the most common illicit substance use disorder in general population. Despite that, only a minority seek assistance from a health professional, but the demand for treatment is now increasing internationally. Trials of treatment have been published but to our knowledge, there is no published systematic review .To evaluate the efficacy of psychosocial interventions for cannabis (...) abuse or dependence.We searched the Cochrane Central Register of Trials (CENTRAL) The Cochrane Library Issue 3, 2004; MEDLINE (January 1966 to August 2004), PsycInfo (1985 to October 2004), CINAHL (1982 to October 2004), Toxibase (until September 2004) and reference lists of articles. We also contacted researchers in the field.All randomized controlled studies examining a psychotherapeutic intervention for cannabis dependence or abuse in comparison with a delayed-treatment control group

2006 Cochrane

135. Cannabis intoxication and fatal road crashes in France: population based case-control study. (PubMed)

Cannabis intoxication and fatal road crashes in France: population based case-control study. To evaluate the relative risk of being responsible for a fatal crash while driving under the influence of cannabis, the prevalence of such drivers within the driving population, and the corresponding share of fatal crashes.Population based case-control study.10 748 drivers, with known drug and alcohol concentrations, who were involved in fatal crashes in France from October 2001 to September 2003 (...) .The cases were the 6766 drivers considered at fault in their crash; the controls were 3006 drivers selected from the 3982 other drivers. Positive detection of cannabis was defined as a blood concentration of Delta9tetrahydrocannabinol of over 1 ng/ml. The prevalence of positive drivers in the driving population was estimated by standardising controls on drivers not at fault who were involved in crashes resulting in slight injuries.681 drivers were positive for cannabis (cases 8.8%, controls 2.8

Full Text available with Trip Pro

2005 BMJ

136. Review: current evidence does not show a strong causal relation between the use of cannabis in young people and psychosocial harm

Review: current evidence does not show a strong causal relation between the use of cannabis in young people and psychosocial harm Review: current evidence does not show a strong causal relation between the use of cannabis in young people and psychosocial harm | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our (...) . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: current evidence does not show a strong causal relation between the use of cannabis in young people and psychosocial harm

Full Text available with Trip Pro

2005 Evidence-Based Mental Health

137. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. (PubMed)

Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. To investigate the relation between cannabis use and psychotic symptoms in individuals with above average predisposition for psychosis who first used cannabis during adolescence.Analysis of prospective data from a population based sample. Assessment of substance use, predisposition for psychosis, and psychotic symptoms was based on standardised personal interviews at baseline (...) and at follow up four years later.2437 young people (aged 14 to 24 years) with and without predisposition for psychosis.Psychotic symptoms at follow up as a function of cannabis use and predisposition for psychosis at baseline.After adjustment for age, sex, socioeconomic status, urbanicity, childhood trauma, predisposition for psychosis at baseline, and use of other drugs, tobacco, and alcohol, cannabis use at baseline increased the cumulative incidence of psychotic symptoms at follow up four years later

Full Text available with Trip Pro

2005 BMJ

138. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. (PubMed)

Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Use of illicit drugs, particularly cannabis, by young people is widespread and is associated with several types of psychological and social harm. These relations might not be causal. Causal relations would suggest that recreational drug use is a substantial public health problem. Non-causal relations would suggest that harm-reduction policy (...) by young people and psychosocial harm.We identified 48 relevant studies, of which 16 were of higher quality and provided the most robust evidence. Fairly consistent associations were noted between cannabis use and both lower educational attainment and increased reported use of other illicit drugs. Less consistent associations were noted between cannabis use and both psychological health problems and problematic behaviour. All these associations seemed to be explicable in terms of non-causal

2004 Lancet

139. The Cannabis Youth Treatment (CYT) study: main findings from two randomized trials

The Cannabis Youth Treatment (CYT) study: main findings from two randomized trials Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2004 NHS Economic Evaluation Database.

140. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. (PubMed)

Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. An association between use of cannabis in adolescence and subsequent risk of schizophrenia was previously reported in a follow up of Swedish conscripts. Arguments were raised that this association may be due to use of drugs other than cannabis and that personality traits may have confounded results. We performed a further analysis of this cohort to address these uncertainties (...) while extending the follow up period to identify additional cases.Historical cohort study.1969-70 survey of Swedish conscripts (>97% of the country's male population aged 18-20).50 087 subjects: data were available on self reported use of cannabis and other drugs, and on several social and psychological characteristics.Admissions to hospital for ICD-8/9 schizophrenia and other psychoses, as determined by record linkage.Cannabis was associated with an increased risk of developing schizophrenia

Full Text available with Trip Pro

2002 BMJ